article thumbnail

Trust in Healthcare is Under Stress in the US and Globally, Edelman Finds

Health Populi

Hospitals’ fall from 70% to 63% between 2018 and 2019. Consumer health’s fall from 63% in 2019 to 51% in 2020. Health insurance’s decline from 55% in 2017 to 46% in 2018, recovering in 2019 then falling again to a low of 43% this year in the 2021 Barometer. The vaccination-willingness gap in the U.S.

BioTech 310
article thumbnail

Aptar Appoints Julie Xing to its Board of Directors

Digital Health Global

With over 20 years of experience in pharmaceutical, medtech, digital health, biotech and diagnosis, Julie’s leadership approach focuses on inspiring teams to deliver sustainable growth in challenging markets and healthcare environments. We are pleased to welcome Julie Xing to our Board of Directors.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Evolution of Self-Care for Consumers – Learning and Sharing at CHPA

Health Populi

Key issues facing the industry in 2019 and into the next few years range from regulation of dietary supplements and the role of CBD in self-care, the omni-channel consumer, ecommerce vs. bricks-and-mortar, trust, and wrestling with consumer privacy. Consumer health went opposite, up 7 points, biotech up 3, insurance up 8, pharma up 6.

BioTech 149
article thumbnail

mHealth guide to Mobile World Congress 2019

mHealth Insight

Best Mobile Innovation for Health and BioTech c. ACCIO-IWC Innovation World Cup Pitch & Award Ceremony 2019 BARCELONA. Centre for Information Policy Leadership. Date & Time. Monday, 25 Feb. 10:00 – 10:30. Description. Fourth Industrial Revolution a. Best Mobile Innovation for Enterprise b. Partner Programmes.

mHealth 28
article thumbnail

Ada Health : beyond symptom checking to the holy grail of healthcare

Lloyd Price

After years of quiet growth, backed by patient investors, however, 2019 is likely to be the year Ada starts making headlines. As a result, more and more investors are paying attention to the health sector which, due to its complexity, has traditionally been left to biotech or medical devices investors.

BioTech 52